| |
|
|
|
|
|
|
Date |
News |
| 19.03.02 |
New Automatic Colorimeter for IP Units and Lovibond Colour
To replace the traditional visual instrument for IP Units, Tintometer Ltd has introduced the Lovibond PFX880/IP17, a spectrophotometric instrument that measures the colour of petroleum products according to both colour scales specified in IP 17 - either Lovibond values (Method A) or IP Units (Method B). Results can also be displayed in terms of CIE values and spectral data. The PFX880/IP17 and should prove to be an attractive alternative as it removes any subjectivity in measurements, especially when grading water-white samples. |
| 01.04.02 |
Ken Stehr has left for Niton to become Director Sales
Kevin Conroy has left for Niton to become Director of New business Developments. Kevin was Sales Manager for the past 11 years at Oxford |
| 10.04.02 |
A SPECTRO van equipped with newest XRF technology has started a demonstration tour throughout Europe:
April 15-27: Slovakia
May 13-17: South Germany
May 20-31: Greece
June 24-July 5: Italy
September 16-20: North and East Germany
November 18-21: Netherlands |
| 12.04.02 |
Tintometer Ltd, The Colour Laboratory will be exhibiting at Analytica 2002, a major event for scientific instrumentation. We can be found in Hall B1 on Stand 168 where we are showing the Lovibond range of colour measuring instruments, including our latest product releases.
Information for visitors is as follows:
Dates: Tuesday 23 April to Friday 26 April 2002
Opening hours: 09:00 - 18:00
Location: New Munich Trade Fair Centre |
| 15.04.02 |
Oxford Instruments Analytical has made 12 of its 365 staff redundant following a "drop in orders as a result of the current worldwide recession" Managing director Charles Holroyd said: "We believe that we are now at the bottom of this fall in orders and see a leveling off" He continued: "Although we have pulled back in-house work that we had been subcontracting, we have been unable to prevent a small number of staff losses". |
| 15.04.02 |
Spectro targets life sciences
Spectro Analytical has created Spectro BioNova to offer an expanded range of analytical tools to the lie science and pharmaceutical sectors. |
| 15.04.02 |
Bruker AXS Acquires MAC Science to Further Penetrate Japanese Life Science and Materials Research Markets.
MADISON, Wis.--(BUSINESS WIRE)--April 18, 2002--Bruker AXS Inc. BAXS, a leading global provider of advanced X-ray solutions for the life and advanced materials sciences, today announced that its wholly owned Japanese subsidiary, Nihon Bruker AXS K.K., has signed a binding agreement to acquire substantially all the assets and certain liabilities of MAC Science Ltd., a Yokohama, Japan-based company focused on X-ray analysis instrumentation. The transaction is expected to close in the second quarter of 2002.
MAC Science was founded in 1987, and has become a significant participant in the Japanese X-ray and thermal analysis instrumentation market. The Japanese X-ray analysis market is estimated to total more than $150 million annually. MAC Science has an established Japanese distribution system with both a direct sales and a service force, as well as an additional distributors network. Since its foundation, MAC Science has installed more than 1,500 systems in Japan and the Pacific Rim.
Bruker AXS entered the Japanese market in 1997 with its CCD-based life-science systems, and has established a strong position in the crystallography market. The new combined business will be located in the Tokyo area to provide strong sales, applications and service support for the existing and future customers of Bruker AXS and MAC Science. The new facility will also house R&D, production and final systems integration for the Japanese market.
Dr. Martin Haase, President and CEO of Bruker AXS, said: "The good market position of MAC Science and its excellent compact X-ray source technology will allow us to further penetrate the large Japanese analytical X-ray market, which we estimate to account for more than 25% of the total world market. Having R&D and an assembly line close to our customers in Japan will enhance our ability to meet their demanding product and support requirements."
"We expect this acquisition to add approximately $2 million to our quarterly revenue, starting in the fourth quarter of 2002," continued Ms. Laura Francis, new CFO of Bruker AXS. "We anticipate that in 2003, this revenue component will begin to grow at our overall revenue target growth rate of greater than 15% per annum. In 2002, we estimate that this acquisition will have a dilutive effect on EPS of approximately $0.02 per share whereas in 2003 we do not expect any dilutive effect of the MAC Science acquisition. We anticipate that by 2004 the MAC Science acquisition will become accretive to our earnings."
Frank H. Laukien, Chairman of Bruker AXS, commented: "I expect that the combined business will give us the critical mass to grow our Japanese business significantly, and that we can become one of the top two players in advanced x-ray solutions in Japan. We believe this acquisition is a great strategic fit for Bruker AXS, and an excellent use of our IPO proceeds. The MAC Science acquisition will grow our technology and customer base, and should further accelerate our revenue and earnings growth."
Mr. Sadao Ueki, President of Nihon Bruker AXS KK, added: "The business combination of Bruker AXS and MAC Science will enable us to significantly broaden our presence in Japan. The dedicated MAC Science management team and employees will integrate well with our existing organization. I am excited about this transaction and foresee an excellent business opportunity for our combined forces."
Mr. Hideo Ohta of MAC Science, Technical Director of the future MAC Science Division of Bruker AXS, stated: "Bruker AXS has an excellent and very innovative product portfolio. When combined with our technologies and market know-how, we expect to become an important presence in the attractive Japanese analytical X-ray market. Our management team and employees are excited to join Bruker AXS. The Bruker AXS strategy to provide innovative technology-leading solutions and high-level in-country support for our customers will be a strong foundation for success." |
| 30.04.02 |
Oxford has made 12 of its 365 staff redundant following a "drop in orders as a result of the current worldwide recession". Managing director Charles Holroyd said: " We believe that we are now at the bottom of this fall in orders and see a levelling off". |
| 05.05.02 |
Bruker AXS Announces Profitable First Quarter 2002 With 26% Revenue Increase
May 9, 2002 5:03pm
Bruker AXS Inc., (NASDAQ: BAXS), a leading global provider of advanced X-ray solutions for the life and advanced materials sciences, today reported its financial results for the first quarter 2002.
Net sales for the three months ended March 31, 2002 increased 26% to $23.8 million, compared to $18.8 million for the three months ended March 31, 2001. After elimination of unfavorable currency effects, revenue growth was 31%.
Net income for the first quarter of 2002 was $0.3 million, or $0.01 per share, compared to $0.00 per share for the first quarter of 2001.
Cash and cash equivalents totaled $53.1 million as of March 31, 2002.
Dr. Martin Haase, President and CEO, stated: "We are very pleased to announce another successful quarter of growth and operating improvements. We exceeded our expectations this quarter for both revenue growth and EBIT. "Later this year we anticipate several new product introductions targeted at the life-science market that should further contribute to our growth objectives," added Dr. Haase. "Furthermore, the recently announced acquisition of MAC Science strengthens our position in the large Japanese market, which is estimated to account for more than 25% of the world X-ray analysis market. With the integration of MAC Science's excellent compact X-ray source technology, we expect to gain market share in this very important region."
"Our healthy backlog provides good top-line visibility for the second quarter and into the third quarter of 2002," said Laura Francis, Chief Financial Officer. "In accordance with previous guidance for the year 2002, we expect robust organic revenue growth of greater than 15%, and earnings per share of $0.03, after the effects of the MAC Science acquisition." |
| 10.05.02 |
New Bruker organisation in Japan: Mac Science closed their Kaga Factory and moved to a new building in Tokyo. They have stopped producing all products except the rotating anode generator. Nihon Bruker ASX KK will now be called Bruker AXS KK. |
|
|
|
|
|
|
|
| UK | Regional news >>>
| Germany | Regional news >>>
